Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as “Lynk Pharmaceuticals”), a clinical-stage innovative drug development company focused on developing innovative therapies for immune and inflammatory diseases, today announced that its innovative TYK2 allosteric inhibitor, LNK01006, has been approved by U.S. Food and Drug Administration (FDA) for human clinical trials. LNK01006 is a highly brain-penetrant, potent, […]

Lightstandard Showcases Breakthrough Photonic Computing Technology at the Saudi Industrial Transformation Expo On December 1, 2025, at the Saudi Industrial Transformation Expo held at the Riyadh International Exhibition Center in Saudi Arabia, an photonic-electronic fusion computing system developed by Lightstandard captured widespread international attention as it simultaneously overcame two major bottlenecks facing the global AI

OneSeven has been awarded a 5-Star Rating for Advisor Support, Growth, and Performance OneSeven, a leading advisor-focused wealth management firm, is honored to be named to Newsweek's America's Top Financial Advisory Firms 2026, earning a 5-star rating across the board. This recognition highlights OneSeven's commitment not only to serving clients but also to empowering advisors

Signaling the rise of Creator revenue streams as investable assets, GigaStar surpasses $1 million in YouTube revenue distributed to investors GigaStar, the startup bringing Creators and Investors together, announced that GigaStar Market platform investors have now received over $1 million in YouTube revenue, confirming market acceptance of investing through GigaStar and in YouTube Creators as

Quest Analytics,the leader in provider network design and management solutions, announced today that the Centers for Medicare & Medicaid Services (CMS) has renewed their contract with Quest Analytics for an additional five-year term. The renewed agreement builds on an almost two-decade long partnership that has driven innovation in network adequacy and accuracy measurement. https://mma.prnewswire.com/media/1162215/Quest_Analytics_updated_Logo.jpg Since

NEW YORK CITY, NY / ACCESS Newswire / December 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

RNA Therapeutics and Vaccines Market to Soar USD 107.7 Billion by 2034 at Explosive 87% CAGR, Driven by Breakthrough RNA Technologies The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around USD 107.7 billion by 2034, rising at a 87% CAGR, a study

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company GlobeNewswire December 02, 2025 BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its fully human anti-IL-6 receptor (IL-6R) monoclonal antibody,

Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook GlobeNewswire December 02, 2025 VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company”) is pleased to provide a corporate update following its recently released Q3 financial results and investor webinar. On November 26, 2025, Hydreight

Nano Labs Announces Annual General Meeting GlobeNewswire December 02, 2025 HONG KONG, Dec. 02, 2025 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced that it will hold its 2025 Annual General Meeting of Shareholders (the “2025 Annual Meeting”)